Mobile AUC App Update Encourages Appropriate Use of TEE, Contrast and Stress Imaging

July 3, 2014 — The American Society of Echocardiography Foundation (ASEF) launched the second version of its free mobile Echo AUC app at the ASE Silver Anniversary Scientific Sessions in Portland, Ore., last week. The app, made possible by a grant from the ABIM Foundation and supported by the Robert Wood Johnson Foundation, was designed by physicians to assist other healthcare practitioners to follow appropriate care guidelines when ordering cardiovascular imaging tests, as part of the Choosing Wisely initiative.

The original version of the app was launched in the fall of 2013, and included all 98 indications for transthoracic echocardiography (TTE) from the 2011 Appropriate Use Criteria (AUC) document. Version 2.0 adds the remaining 104 indications, which encompass three additional echo modalities: transesophageal echo (TEE), stress echo (SE) and contrast echo (CE). Plus, there are six new algorithms for stress echo that help guide physicians in additional detail to determine if stress echo is appropriate in various scenarios.

“Adding the indications for three new modalities, especially SE, is an extremely valuable and important update for the Echo AUC app,” said David Wiener, M.D., FASE, director of clinical operations at the Jefferson Heart Institute. “Stress echo tends to be ordered quite often by non-cardiologists, and there is a great need for education regarding appropriate ordering in this modality. Also, many clinicians underutilize contrast echocardiography for various reasons; the updated app reminds us that contrast should be used any time we cannot clearly see two or more contiguous LV segments.”

ASE supports the use of contrast to assist practitioners in reducing sub-optimal images that will ultimately reduce duplicative testing.

The latest version of the Echo AUC app also includes new "Five Things Physicians and Patients Should Question" lists developed by ASE and other participating specialty societies as part of the Choosing Wisely campaign. These lists are evidence-based recommendations that can be utilized to help make wise decisions about the most appropriate care based on a patient's individual situation.

For more information: www.asecho.org


Related Content

News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 8, 2024 — Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive technique for neuroregulation ...

Time April 08, 2024
arrow
News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Radiology Business

April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time April 04, 2024
arrow
News | Radiation Oncology

April 2, 2024 — In a 10-center study, microwave ablation offered progression free survival rates and fewer complications ...

Time April 02, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | Coronavirus (COVID-19)

March 21, 2024 — Artificial intelligence can spot COVID-19 in lung ultrasound images much like facial recognition ...

Time March 21, 2024
arrow
News | Breast Imaging

March 8, 2024 — Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies ...

Time March 08, 2024
arrow
News | FDA

March 6, 2024 — Lantheus Holdings, Inc. (Lantheus), a radiopharmaceutical company, has announced that the U.S. Food and ...

Time March 06, 2024
arrow
News | Point-of-Care Ultrasound (POCUS)

February 13, 2024 — Butterfly Network, Inc., a digital health company transforming care through the power of portable ...

Time February 13, 2024
arrow
Subscribe Now